pembrolizumab,pds0101
pds biotech,merck
['$pdsb']
$pdsb can't stress enough how important this recent asco data is - specifically os/pfs. frank discussed this on the q4 call...they are absolutely going to seek accelerated approval for the ph3 trial &amp; i have a high level of confidence they'll get it 